Actions

::(-)-2β-(3-(4-Methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane

::concepts



{{#invoke:Infobox|infobox}}{{#invoke:TemplatePar |check |template=Template:Infobox_drug |all= |opt= pronounce= ATC_prefix= ATC_suffix= ATC_supplemental= ATCvet= CAS_number_Ref= CAS_number= CAS_supplemental= ChEBI= ChEBI_Ref= ChEMBL_Ref= ChEMBL= ChemSpiderID= ChemSpiderID_Ref= ChemSpiderID= DailyMedID= data_page= DrugBank_Ref= DrugBank= Drugs.com= duration_of_action= IUPAC_name= IUPHAR_ligand= KEGG_Ref= KEGG= MedlinePlus= NIAID_ChemDB= PDB_ligand= PubChemSubstance= PubChem= StdInChIKey_Ref= StdInChIKey_comment= StdInChIKey= StdInChI_Ref= StdInChI_comment= StdInChI= UNII_Ref= UNII= Verifiedfields= Watchedfields= addiction_liability= alt2= altL= altR= alt= bioavailability= boiling_high= boiling_notes= boiling_point= captionLR= caption= charge= chemical_formula= chemical_formula_ref= chemical_formula_comment= class1= class2= class3= class4= component1= component2= component3= component4= density= dependency_liability= drug_name= elimination_half-life= excretion= InChI= InChIKey= image2= imageL= imageR= imagename= image= legal_AU= legal_CA= legal_DE= legal_EU= legal_NZ= legal_UK= legal_UN= legal_US= legal_AU_comment= legal_CA_comment= legal_DE_comment= legal_UK_comment= legal_NZ_comment= legal_US_comment= legal_UN_comment= legal_EU_comment= legal_status= licence_EU= licence_US= mab_type= melting_high= melting_notes= melting_point= metabolism= metabolites= molecular_weight= molecular_weight_round= molecular_weight_unit= molecular_weight_ref= molecular_weight_comment= onset= pregnancy_AU= pregnancy_US= pregnancy_AU_comment= pregnancy_US_comment= pregnancy_category= protein_bound= routes_of_administration= sec_combustion= SMILES= smiles= solubility= source= specific_rotation= synonyms= target= tradename= type= vaccine_type= verifiedrevid= width2= widthL= widthR= width= Ac=Ag=Al=Am=Ar=As=At=Au=B=Ba=Be=Bh=Bi=Bk=Br=C=Ca=Cd=Ce=Cf=Cl=Cm=Cn=Co=Cr=Cs=Cu= Db=Ds=Dy=Er=Es=Eu=F=Fe=Fl=Fm=Fr=Ga=Gd=Ge=H=He=Hf=Hg=Ho=Hs=I=In=Ir=K=Kr=La=Li=Lr=Lu=Lv= Md=Mg=Mn=Mo=Mt=N=Na=Nb=Nd=Ne=Ni=No=Np=O=Os=P=Pa=Pb=Pd=Pm=Po=Pr=Pt=Pu=Ra=Rb=Re=Rf=Rg=Rh=Rn=Ru= S=Sb=Sc=Se=Sg=Si=Sm=Sn=Sr=Ta=Tb=Tc=Te=Th=Ti=Tl=Tm=U=Uuo=Uup=Uus=Uut=V=W=Xe=Y=Yb=Zn=Zr |cat=Chemical articles with unknown parameter in Infobox drug |format=0|preview=1|errNS=0 }}

RTI-336, (LS-193,309, (−)-2β-(3-(4-methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane) is a phenyltropane derivative which acts as a potent and selective dopamine reuptake inhibitor and stimulant drug. It binds to the dopamine transporter with around 20x the affinity of cocaine,<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> however it produces relatively mild stimulant effects, with a slow onset and long duration of action.<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> These characteristics make it a potential candidate for treatment of cocaine addiction, as a possible substitute drug analogous to how methadone is used for treating heroin abuse.<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref><ref>Sofuoglu M, Kosten TR. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion on Emerging Drugs. 2006 Mar;11(1):91-98. doi:10.1517/14728214.11.1.91</ref> RTI-336 fully substitutes for cocaine in addicted monkeys and supports self-administration,<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref><ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> and significantly reduces rates of cocaine use, especially when combined with SSRIs,<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> and research is ongoing to determine whether it could be a viable substitute drug in human cocaine addicts.


(-)-2β-(3-(4-Methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane sections
Intro  Update  Pharmacotherapy for Cocaine Abuse   See also   References  

PREVIOUS: IntroNEXT: Update
<<>>

First::journal    Cocaine::dopamine    Issue::pages    Volume::carroll    Title::align    Center::category

{{#invoke:Infobox|infobox}}{{#invoke:TemplatePar |check |template=Template:Infobox_drug |all= |opt= pronounce= ATC_prefix= ATC_suffix= ATC_supplemental= ATCvet= CAS_number_Ref= CAS_number= CAS_supplemental= ChEBI= ChEBI_Ref= ChEMBL_Ref= ChEMBL= ChemSpiderID= ChemSpiderID_Ref= ChemSpiderID= DailyMedID= data_page= DrugBank_Ref= DrugBank= Drugs.com= duration_of_action= IUPAC_name= IUPHAR_ligand= KEGG_Ref= KEGG= MedlinePlus= NIAID_ChemDB= PDB_ligand= PubChemSubstance= PubChem= StdInChIKey_Ref= StdInChIKey_comment= StdInChIKey= StdInChI_Ref= StdInChI_comment= StdInChI= UNII_Ref= UNII= Verifiedfields= Watchedfields= addiction_liability= alt2= altL= altR= alt= bioavailability= boiling_high= boiling_notes= boiling_point= captionLR= caption= charge= chemical_formula= chemical_formula_ref= chemical_formula_comment= class1= class2= class3= class4= component1= component2= component3= component4= density= dependency_liability= drug_name= elimination_half-life= excretion= InChI= InChIKey= image2= imageL= imageR= imagename= image= legal_AU= legal_CA= legal_DE= legal_EU= legal_NZ= legal_UK= legal_UN= legal_US= legal_AU_comment= legal_CA_comment= legal_DE_comment= legal_UK_comment= legal_NZ_comment= legal_US_comment= legal_UN_comment= legal_EU_comment= legal_status= licence_EU= licence_US= mab_type= melting_high= melting_notes= melting_point= metabolism= metabolites= molecular_weight= molecular_weight_round= molecular_weight_unit= molecular_weight_ref= molecular_weight_comment= onset= pregnancy_AU= pregnancy_US= pregnancy_AU_comment= pregnancy_US_comment= pregnancy_category= protein_bound= routes_of_administration= sec_combustion= SMILES= smiles= solubility= source= specific_rotation= synonyms= target= tradename= type= vaccine_type= verifiedrevid= width2= widthL= widthR= width= Ac=Ag=Al=Am=Ar=As=At=Au=B=Ba=Be=Bh=Bi=Bk=Br=C=Ca=Cd=Ce=Cf=Cl=Cm=Cn=Co=Cr=Cs=Cu= Db=Ds=Dy=Er=Es=Eu=F=Fe=Fl=Fm=Fr=Ga=Gd=Ge=H=He=Hf=Hg=Ho=Hs=I=In=Ir=K=Kr=La=Li=Lr=Lu=Lv= Md=Mg=Mn=Mo=Mt=N=Na=Nb=Nd=Ne=Ni=No=Np=O=Os=P=Pa=Pb=Pd=Pm=Po=Pr=Pt=Pu=Ra=Rb=Re=Rf=Rg=Rh=Rn=Ru= S=Sb=Sc=Se=Sg=Si=Sm=Sn=Sr=Ta=Tb=Tc=Te=Th=Ti=Tl=Tm=U=Uuo=Uup=Uus=Uut=V=W=Xe=Y=Yb=Zn=Zr |cat=Chemical articles with unknown parameter in Infobox drug |format=0|preview=1|errNS=0 }}

RTI-336, (LS-193,309, (−)-2β-(3-(4-methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane) is a phenyltropane derivative which acts as a potent and selective dopamine reuptake inhibitor and stimulant drug. It binds to the dopamine transporter with around 20x the affinity of cocaine,<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> however it produces relatively mild stimulant effects, with a slow onset and long duration of action.<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> These characteristics make it a potential candidate for treatment of cocaine addiction, as a possible substitute drug analogous to how methadone is used for treating heroin abuse.<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref><ref>Sofuoglu M, Kosten TR. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion on Emerging Drugs. 2006 Mar;11(1):91-98. doi:10.1517/14728214.11.1.91</ref> RTI-336 fully substitutes for cocaine in addicted monkeys and supports self-administration,<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref><ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> and significantly reduces rates of cocaine use, especially when combined with SSRIs,<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref> and research is ongoing to determine whether it could be a viable substitute drug in human cocaine addicts.


(-)-2β-(3-(4-Methylphenyl)isoxazol-5-yl)-3β-(4-chlorophenyl)tropane sections
Intro  Update  Pharmacotherapy for Cocaine Abuse   See also   References  

PREVIOUS: IntroNEXT: Update
<<>>